Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 5 Total
AVTE - Aerovate Therapeutics Inc - Stock Price Chart
TickerAVTE [NASD, RUT]
CompanyAerovate Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap40.64MEPS (ttm)-3.03
P/E-EPS this Y-2.29%
Forward P/E-EPS next Y40.44%
PEG-EPS past 5Y-114.14%
P/S-EPS next 5Y-
P/B0.43EPS Q/Q-25.12%
Dividend-Sales Q/Q-
Insider Own33.29%Inst Own64.74%
Insider Trans-2.65%Inst Trans4.19%
Short Float11.49%EarningsMay 13/a
Analyst Recom3.00Target Price2.25
Avg Volume607.81K52W Range1.50 - 32.42
Jun-18-24Downgrade Wells Fargo Overweight → Equal Weight $35 → $2
Jun-18-24Downgrade TD Cowen Buy → Hold
Jun-18-24Downgrade Evercore ISI Outperform → In-line $27 → $2
Jun-18-24 09:21AM Aerovate (AVTE) Down as Lead Drug Fails to Meet PAH Study Goals (Zacks) -14.55%
Jun-17-24 04:11PM Aerovate Therapeutics Stock Dropped Over 90%. Heres Why. (Barrons.com) -93.30%
04:04PM Why 93% Of Aerovate Therapeutics' Value Just Went Up In Smoke (Investor's Business Daily)
08:32AM Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension (GlobeNewswire)
May-21-24 04:15PM Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference (GlobeNewswire) -9.04%
May-13-24 09:54PM AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q1 2024 (InvestorPlace)
04:30PM Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights (GlobeNewswire)
Apr-04-24 01:31AM Aerovate Therapeutics Inc CEO Timothy Noyes Sells 10,000 Shares (GuruFocus.com)
Mar-27-24 09:20AM Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference (GlobeNewswire) +11.11%
Mar-26-24 09:01PM Aerovate Therapeutics Inc (AVTE) Reports Increased R&D Expenses and Net Loss in 2023 (GuruFocus.com)
EQH - Equitable Holdings Inc - Stock Price Chart
TickerEQH [NYSE]
CompanyEquitable Holdings Inc
CountryUSA
IndustryInsurance - Diversified
Market Cap13.02BEPS (ttm)3.23
P/E12.40EPS this Y33.29%
Forward P/E5.56EPS next Y17.68%
PEG0.65EPS past 5Y1.22%
P/S0.98EPS next 5Y19.00%
P/B27.90EPS Q/Q-32.86%
Dividend2.33%Sales Q/Q42.49%
Insider Own0.48%Inst Own99.94%
Insider Trans-25.03%Inst Trans-0.24%
Short Float1.32%EarningsApr 30/a
Analyst Recom2.00Target Price43.11
Avg Volume2.57M52W Range24.65 - 41.64
Jun-18-24Downgrade UBS Buy → Neutral $40 → $43
Jun-17-24 07:01PM Insider Sale: COO Jeffrey Hurd Sells Shares of Equitable Holdings Inc (EQH) (GuruFocus.com)
02:30PM Equitable Holdings Announces Pricing Terms of Cash Tender Offer for Certain of its Debt Securities (Business Wire)
08:30AM Equitable Holdings Announces Early Results and Upsizing of Cash Tender Offer of Its Debt Securities (Business Wire)
Jun-06-24 09:30AM Equitable Enhances Corporate Endowment Solutions Platform (Business Wire)
Jun-03-24 08:15AM Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities (Business Wire)
May-27-24 09:23PM The Best Place to Live on Only a Social Security Check (Insider Monkey)
09:21PM 20 Best Places to Live on Only a Social Security Check (Insider Monkey)
May-23-24 04:15PM Equitable Holdings to Participate in the 2024 Morgan Stanley US Financials, Payments and CRE Conference (Business Wire)
10:15AM Equitable Holdings' (EQH) Board Boosts Quarterly Dividend by 9% (Zacks)
May-22-24 04:30PM Peter Tian Appointed Group Treasurer of Equitable Holdings (Business Wire)
FSLR - First Solar Inc - Stock Price Chart
TickerFSLR [NASD, S&P 500]
CompanyFirst Solar Inc
CountryUSA
IndustrySolar
Market Cap28.08BEPS (ttm)9.54
P/E27.51EPS this Y75.64%
Forward P/E12.43EPS next Y55.24%
PEG0.47EPS past 5Y41.58%
P/S7.88EPS next 5Y58.00%
P/B4.07EPS Q/Q454.63%
Dividend-Sales Q/Q44.83%
Insider Own5.60%Inst Own90.31%
Insider Trans-2.53%Inst Trans2.01%
Short Float5.57%EarningsMay 01/a
Analyst Recom1.65Target Price283.76
Avg Volume2.70M52W Range129.21 - 306.77
Jun-18-24Downgrade Janney Buy → Neutral
Jun-18-24 05:45PM First Solar (FSLR) Laps the Stock Market: Here's Why (Zacks)
09:51AM Apple downgraded, Kroger upgraded: Wall Street's top analyst calls (The Fly)
Jun-17-24 05:01PM S&P 500 Gains and Losses Today: Autodesk Jumps After Reports of Activist Stake (Investopedia)
04:26PM Tesla, Broadcom Among S&P 500 Stock Winners Monday. First Solar Leads Losers. (Investor's Business Daily)
07:15AM Breakout Alert! 7 Stocks Wall Street Is Sending to the Moon (InvestorPlace)
Jun-15-24 06:49AM The 3 Best Solar Stocks to Buy in June 2024 (InvestorPlace)
Jun-14-24 08:09PM Analyst Report: First Solar, Inc. (Morningstar Research) -6.16%
07:17PM Tesla Stock Will Ride Higher on Musks Pay Raise. Plus, GM, Warner Bros., and More. (Barrons.com)
06:11PM ENPH vs. FSLR: Which Solar Stock Is the Better Buy? (TipRanks)
04:58PM S&P 500 Gains and Losses Today: Adobe Becomes Latest Stock to Enjoy AI Boost (Investopedia)
OVID - Ovid Therapeutics Inc - Stock Price Chart
TickerOVID [NASD, RUT]
CompanyOvid Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap55.89MEPS (ttm)-0.72
P/E-EPS this Y-11.45%
Forward P/E-EPS next Y23.16%
PEG-EPS past 5Y18.87%
P/S118.92EPS next 5Y-
P/B0.71EPS Q/Q12.72%
Dividend-Sales Q/Q123.70%
Insider Own18.85%Inst Own60.18%
Insider Trans0.14%Inst Trans2.23%
Short Float4.98%EarningsMay 14/b
Analyst Recom1.40Target Price3.17
Avg Volume529.04K52W Range0.75 - 4.14
Jun-18-24Downgrade Oppenheimer Outperform → Perform
Jun-18-24 09:51AM Apple downgraded, Kroger upgraded: Wall Street's top analyst calls (The Fly)
Jun-17-24 01:45PM Is the Stock Market Closed on Juneteenth 2024? (InvestorPlace) -76.00%
01:28PM ACHR Stock Alert: Archer Aviation Strikes New Deal With Signature Aviation (InvestorPlace)
01:03PM AAN Stock Alert: The Aaron's Company Pops 33% on Take-Private Deal (InvestorPlace)
12:38PM Why Is Ovid Therapeutics (OVID) Stock Down 69% Today? (InvestorPlace)
08:07AM Takeda drug for rare types of epilepsy misses goal in late-stage trial (BioPharma Dive)
06:55AM Ovid Therapeutics Reports on Takeda's Announcement of Phase 3 Topline Study Results for Soticlestat (GlobeNewswire)
May-28-24 01:09PM 3 Sorry Penny Stocks to Sell in May While You Still Can (InvestorPlace)
May-20-24 06:00AM Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
May-14-24 01:54PM OVID Stock Earnings: Ovid Therapeutics Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +6.95%
ZNTL - Zentalis Pharmaceuticals Inc - Stock Price Chart
TickerZNTL [NASD, RUT]
CompanyZentalis Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap293.98MEPS (ttm)-3.36
P/E-EPS this Y39.51%
Forward P/E-EPS next Y-34.28%
PEG-EPS past 5Y-50.05%
P/S7.25EPS next 5Y-
P/B0.64EPS Q/Q113.26%
Dividend-Sales Q/Q-
Insider Own12.31%Inst Own113.65%
Insider Trans-0.48%Inst Trans-0.93%
Short Float28.13%EarningsMay 07/b
Analyst Recom2.20Target Price12.11
Avg Volume653.22K52W Range8.25 - 30.53
Jun-18-24Downgrade Wells Fargo Overweight → Equal Weight
Jun-18-24Downgrade Wedbush Neutral → Underperform $15 → $4
Jun-18-24Downgrade Morgan Stanley Overweight → Equal-Weight $38 → $8
Jun-18-24Downgrade Jefferies Buy → Hold $42 → $6
Today 04:52AM FDA places partial clinical hold on Zentalis trials of azenosertib for cancer (Clinical Trials Arena)
Jun-18-24 07:00AM Zentalis Pharmaceuticals Provides Update on Azenosertib Clinical Development Program (GlobeNewswire) -50.66%
Jun-03-24 06:00PM Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-01-24 02:43AM Insider Selling at Zentalis Pharmaceuticals Inc (ZNTL): President, Interim CFO Cam Gallagher ... (GuruFocus.com)
May-30-24 07:00AM Zentalis Pharmaceuticals to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-29-24 07:00AM Zentalis Pharmaceuticals Announces Appointment of Accomplished Oncology Drug Developer Luke Walker, M.D., to Board of Directors (GlobeNewswire)
May-23-24 05:01PM Zentalis Pharmaceuticals to Present Promising Results from Phase 1 Trial of Azenosertib and Gemcitabine in Relapsed or Refractory Osteosarcoma at 2024 American Society of Clinical Oncology Annual Meeting (GlobeNewswire) -5.84%
May-14-24 07:00AM Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit (GlobeNewswire)
May-08-24 10:27AM Stifel Adjusts Price Target on Zentalis Pharmaceuticals to $32 From $36, Maintains Buy Rating (MT Newswires)
May-07-24 09:04PM Zentalis Pharmaceuticals Reports Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic ... (GuruFocus.com) +5.03%
1
affiliate • advertise • careers • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.